| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 13.0 | 10.1 | +29.3% |
| EBITDA | 7.3 | 6.0 | +20.4% |
| EBITDA margin | 55.9% | 60.1% | −4.1 pts |
| Profit before tax | 4.0 | 3.8 | +4.9% |
| Net profit | 2.9 | 2.8 | +4.5% |
| EPS | ₹2.53 | ₹2.49 | +1.6% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 119 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.2 | 0.2 | 30.5 | 19.3 | 11.7 | ||
| 56.8 | 56.8 | 47.2 | 28.9 | 12.0 | ||
| 176 | — | — | — | — | ||
| 42.7 | 39.7 | 35.0 | 28.1 | 19.3 | ||
| — | +13.4% | +24.7% | +45.8% | — | ||
| 22.2 | 20.9 | 20.5 | 15.1 | 4.7 | ||
| 52.0% | 52.7% | 58.5% | 53.8% | 24.2% | ||
| 14.4 | 13.6 | 14.5 | 8.2 | 2.0 | ||
| 9.0 | 8.9 | 19.0 | 5.5 | 3.9 | ||
| 21.1% | 22.3% | 54.2% | 19.6% | 20.2% | ||
| ₹7.78 | ₹7.65 | ₹16.38 | ₹4.75 | ₹3.37 | ||
| — | −53.3% | +244.6% | +41.2% | — | ||
| — | 9.5 | 47.7 | 55.7 | 10.8 | ||
| — | −29.7 | −51.1 | −59.4 | −13.3 | ||
| −20.2 | −20.2 | −3.4 | −3.7 | −2.4 | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 119.4 | |
| - Cash, Equiv & ST Investments | 11.7 | 19.3 | 30.5 | 0.2 | 0.2 | |
| + Total Debt | 12.0 | 28.9 | 47.2 | 56.8 | 56.8 | |
| Enterprise Value | — | — | — | — | 176.0 | |
| Revenue | 19.3 | 28.1 | 35.0 | 39.7 | 42.7 | |
| Growth %, YoY | — | +45.8 | +24.7 | +13.4 | — | |
| EBITDA | 4.7 | 15.1 | 20.5 | 20.9 | 22.2 | |
| Margin % | 24.23 | 53.84 | 58.53 | 52.72 | 52.01 | |
| EBIT | 2.0 | 8.2 | 14.5 | 13.6 | 14.4 | |
| Net Income | 3.9 | 5.5 | 19.0 | 8.9 | 9.0 | |
| Margin % | 20.23 | 19.60 | 54.18 | 22.33 | 21.13 | |
| EPS, Adj (current shares) | 3.37 | 4.75 | 16.38 | 7.65 | 7.78 | |
| Growth %, YoY | — | +41.2 | +244.6 | -53.3 | — | |
| Cash from Operations | 10.8 | 55.7 | 47.7 | 9.5 | — | |
| Capital Expenditures | -13.3 | -59.4 | -51.1 | -29.7 | — | |
| Free Cash Flow | -2.4 | -3.7 | -3.4 | -20.2 | -20.2 | |
Prices at the previous close · figures from the company's filings with NSE
Crown Lifters (NSE: CROWN) had a market capitalisation of ₹119 crore at the previous close (₹103.00 a share), a PE ratio of 13.2 on the last four quarters' profit and a price-to-book ratio of 1.54. In FY26 its consolidated net profit was ₹8.9 crore on revenue of ₹39.7 crore; in Q1 FY27 (April–June 2026) it was ₹2.9 crore, up 4.5% year on year. Its debt-to-equity ratio was 0.73 on 31 March 2026. Promoters held 67.82% of the shares on 30 September 2026.
Crown Lifters' PE ratio is 13.2 at the previous close (₹103.00 a share): a market capitalisation of ₹119 crore divided by consolidated net profit of ₹9 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹8.9 crore) it is 13.5.
Crown Lifters' debt-to-equity ratio was 0.73 on 31 March 2026: borrowings of ₹56.8 crore against total equity of ₹77.4 crore. A year earlier, on 31 March 2025, it was 0.76.
Crown Lifters' net worth — shareholders' equity in its consolidated balance sheet — was ₹77.4 crore on 31 March 2026, up 25.2% from ₹61.8 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹119 crore at the previous close.
Crown Lifters' price-to-book (PB) ratio is 1.54 at the previous close: a market capitalisation of ₹119 crore divided by shareholders' equity (book value) of ₹77.4 crore on 31 March 2026. That is a book value of ₹66.76 per share against a share price of ₹103.00.
In FY26, Crown Lifters' return on equity (ROE) was 12.8% and its return on capital employed (ROCE) was 10.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 38.8% and ROCE 15.0%.
Crown Lifters' book value per share was ₹66.76 on 31 March 2026: shareholders' equity of ₹77.4 crore divided by the 1.16 crore shares in issue, up 21.2% from ₹55.09 a year earlier. The share price at the previous close was ₹103.00.
Crown Lifters' market capitalisation was ₹119 crore at the previous close: 1.16 crore shares at ₹103.00 each.
Crown Lifters' basic earnings per share (EPS) were ₹7.72 in FY26, against ₹16.91 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹7.85.
Crown Lifters will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, the date of the board meeting it has notified to the exchanges.
No. Crown Lifters had borrowings of ₹56.8 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.73. Its cash and current investments were ₹15 lakh, so its net debt was ₹56.6 crore.
Promoters held 67.82% of Crown Lifters on 30 September 2026, unchanged from the previous quarter and down 1.74 percentage points from 69.56% a year earlier, according to the shareholding pattern filed with NSE.
On 30 September 2026, Crown Lifters' shares were held by promoters 67.82%, domestic institutions (DII) 0.06% and retail and other non-institutional investors 32.12%.
In FY26, Crown Lifters generated ₹9.5 crore of cash from operations and spent ₹29.7 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹20.2 crore. In FY25 it was −₹3.4 crore.
Crown Lifters' latest results are for Q1 FY27 (April–June 2026), filed on 23 July 2026: consolidated net profit ₹2.9 crore, up 4.5% from ₹2.8 crore in Q1 FY26; revenue from operations ₹13 crore, up 29.3% year on year.
In FY26 (April 2025–March 2026), Crown Lifters' consolidated net profit was ₹8.9 crore, down 53.3% from ₹19 crore in FY25, on revenue from operations of ₹39.7 crore (up 13.4%). Over three years, from FY23, net profit was up 127.4%.
On FY26 consolidated figures, against Hindcon Chemicals, Par Drugs And Chemicals and BALAXI PHARMACEUTICALS: Crown Lifters' operating margin of 34.2% is the highest of the four (Hindcon Chemicals 4.1%, Par Drugs And Chemicals 13.0%, BALAXI PHARMACEUTICALS 2.4%; peer average 6.5%); its return on equity of 12.8% is the highest of the four (Hindcon Chemicals 5.8%, Par Drugs And Chemicals 12.4%, BALAXI PHARMACEUTICALS 0.6%; peer average 6.3%); its revenue growth over three years of 27.3% a year is the highest of the four (Hindcon Chemicals −8.8% a year, Par Drugs And Chemicals 2.7% a year, BALAXI PHARMACEUTICALS −7.1% a year; peer average −4.4% a year).
In FY26, Crown Lifters earned net profit of ₹8.9 crore on revenue of ₹39.7 crore, against ₹3.2 crore on ₹65 crore for Hindcon Chemicals. Crown Lifters' operating margin was 34.2% (Hindcon Chemicals 4.1%) and its return on equity 12.8% (Hindcon Chemicals 5.8%).
From Crown Lifters' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.